Daxor Corp (DXR.A)

DXR.A on American Stock Exchange

19 Nov 2014
Price Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for DXR.A


Daxor Corporation is a medical device manufacturing company which provides additional biotechnology services. The Company focuses on the creation and development of the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. This instrument is used in conjunction with Volumex , a single-use radiopharmaceut... (more)
No analyst recommendations are available for DXR.A.


Beta: 0.04
Market Cap (Mil.): $27.92
Shares Outstanding (Mil.): 4.03
Dividend: 0.03
Yield (%): 1.16


  DXR.A Industry Sector
P/E (TTM): -- 31.66 39.20
EPS (TTM): -1.07 -- --
ROI: -15.19 8.42 17.16
ROE: -15.82 13.18 18.09
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
Provider: Pechala's Reports
Provider: Reuters Investment Profile
Provider: S&P Capital IQ Quantitative Report
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks